ICH Q3D新药制剂元素杂质评估及控制的要点解读
({{custom_author.role_cn}}), {{javascript:window.custom_author_cn_index++;}}Interpretation of Key Points of Assessment and Control of Elemental Impurities in New Drug Preparations for ICH Q3D Guideline
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |
